News | News By Subject | News by Disease News By Date | Search News

Investor News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited     10/24/2014
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid     10/24/2014
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst     10/24/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen     10/23/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier     10/23/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts     10/22/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt     10/21/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts     10/21/2014
AbbVie (ABBV) Still A Buy Despite Shire Fallout, Says Analyst     10/17/2014
Cowen and Company: Best Buys, Favorable Biotech Outlook Remain     10/17/2014
Roche (RHHBY) Lucentis, Regeneron (REGN) Eylea Continue To Battle It Out In Eye Market     10/16/2014
Agios Pharmaceuticals (AGIO) Smart Buy Ahead Of Cancer Data: Citi     10/16/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War     10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma     10/15/2014
Selecta Biosciences, Inc. Announces More Than $20 Million In Equity Funding     10/15/2014

Featured Stories
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC     10/20/2014
Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist     10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC     10/20/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing     10/15/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech     10/10/2014
Cross-Over Investing All The Rage, Say VCs On Panel     10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO     10/8/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report     10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas     10/3/2014
What Happened At BioPharm America 2014?     9/24/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential     8/26/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars     8/12/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN)     7/3/2014
What Biotech Experts Will Be Chirping About at JP Morgan This Week     1/13/2014
Analyst Uncovers Why Investors Should Pay Attention To Cytori Therapeutics, Inc. (CYTX)     11/22/2013
PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change And Launches New Corporate Website     10/24/2014
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $6 Million     10/24/2014
Amgen (AMGN) To Webcast 2014 Business Review Meeting On October 28     10/24/2014
Zafgen (ZFGN) To Ring The Nasdaq Stock Market Closing Bell     10/24/2014
AptarGroup Declares Quarterly Dividend     10/24/2014
Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P     10/24/2014
Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan     10/23/2014
Celator Pharmaceuticals, Inc. Announces Pricing Of A $12.9 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock     10/23/2014
Notice Of Extraordinary General Meeting Of Medivir AB (MVRBF) (Publ)     10/23/2014
TetraPhase PharmaceuticalsAnnounces Closing Of Public Offering Of Common Stock     10/23/2014
Bioren, Inc. Announces Additional Orders For $1.7 Million     10/22/2014
Amgen (AMGN) Statement Regarding Third Point Investment     10/22/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program     10/22/2014
Clovis Oncology (CLVS) To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6     10/22/2014
Flexion Therapeutics (FLXN) To Ring The Nasdaq Stock Market Opening Bel     10/22/2014

More News
No News Posted on that date

Career Tips
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014
Get A Biotech Job By Thinking Like A Hiring Manager     10/9/2014
7 Deadly Interview Sins     10/9/2014
3 Ways To Uncover A Hidden Job     10/9/2014
3 Crucial Areas To Ask About During The Interview     10/9/2014
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation (LMNX)     9/26/2014
The One Job Search Technique That Eliminates Your Competition     9/25/2014
The Secret To Being The Only Person Applying For the Job     9/25/2014
5 Golden Rules For Negotiating Salary     9/25/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->